Brief: Lineage Cell Therapeutics Reports Third Quarter 2020 Financial Results And Provides Business Update
04/11/2020 22:35
Nov 4 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 REVENUE $600,000
* QTRLY LOSS PER SHARE $0.05
Source text for Eikon: ID:nBw22spj5a
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million